Trader Note — 9789 total
CRK enters its June 2 earnings call with the stock down 22% over the past month, short sellers near their most aggressive positioning in six weeks, and every analyst who has moved this week heading in the same…
Spire Global reported earnings on May 27 and the market's verdict was swift — the stock closed at $23.75, up 12% on the day and 24% on the week, with short sellers now nursing losses on a position that has been…
PDD Holdings has just delivered its Q1 2026 results, and the immediate read is a familiar one — a beat on the numbers, a cut on the targets. The most telling post-earnings signal is what analysts did within hours of…
Verra Mobility enters a critical inflection point as five analyst desks cut their ratings in a single morning — a coordinated wave of downgrades that wiped the stock to $13.08 and reshaped the Street's view of the…
Bloom Energy has added 16% this week to $302.40, extending its post-earnings momentum — yet nearly every insider with discretionary authority has been selling into the strength. The insider activity is the standout…
Xiaomi Corporation enters the final days of May with an unusual split: a strong Q1 earnings print on one side and a fresh bearish call from a major bank on the other. That tension is the week's defining feature. Short…
Champion Homes heads into the final days of May with a sharp disconnect: the stock just posted its best week in months, yet two sell-side firms cut their price targets the same morning. The options market tells the…
Talos Energy heads into the final days of May in a striking contradiction: analysts are lifting price targets across the board, yet the stock is down nearly 11% on the week, driven by a prominent insider offloading…
AVGO has recovered the ground lost during last week's consolidation, with the stock closing at $422.01 — up 2.7% on the week and back within striking distance of the analyst target cluster sitting in the $480–$545…
Zscaler delivered its fiscal Q3 print on May 26, and the market's verdict has been swift: the stock held its ground, but the Street spent the following morning cutting price targets almost across the board. The analyst…
Guardant Health has surged 22% in a week and 35% in a month — and the company's own executives are using the run-up to sell. The insider activity is the standout this week. On May 20, founder and CEO Amirali Talasaz…
Magnolia Oil & Gas heads into the final week of May having shed 6.7% over the past five sessions, trading at $28.15 — a move that looks painful in isolation but tracks almost exactly with the broader E&P complex. The…
DigitalBridge Group heads into its Q1 earnings call — scheduled for tomorrow, May 28 — with a transformative deal dominating the conversation and short sellers in a measured retreat. This morning the company announced…
Lamb Weston enters the last week of May with a striking disconnect between insider conviction and a stock that refuses to cooperate. The most compelling story on LW right now is what insiders are doing with their own…
The Trade Desk is stuck in a painful post-earnings grind — down nearly 8% over the past month and trading at $22.18, with short sellers adding to positions even as the stock attempts a 5% weekly bounce. Short interest…
MDGL heads into its June 17 earnings date with short sellers in modest retreat and a cost-to-borrow that just doubled in a single session, creating a quietly charged setup for a stock that has barely moved in a…
Johnson Controls International enters its next earnings print — scheduled for June 1 — with a freshly upgraded analyst consensus and a stock that has recovered sharply off its lows, leaving the Street debating whether…
e.l.f. Beauty has stabilised after its earnings-day shrug, but the week's data shows a new dynamic taking shape — short sellers are quietly rebuilding positions even as the stock edges higher. Short interest has…
Permian Resources Corporation heads into late May with price weakness accelerating, options traders turning more defensive, and a cluster of insider sales from the spring still fresh in the register. The stock fell…
Altimmune enters the back half of May with its highest-conviction clinical catalyst in years, yet short sellers have barely flinched — a striking standoff between data momentum and a deeply entrenched bear camp. Short…
